Two painkillers recalled in the U.S. have now been recalled in Canada, Health Canada says.
The health agency announced Friday that Excedrin Extra Strength Caplets and Excedrin Headache Caplets have been recalled after U.S. reports of chipped and broken pills and inconsistent bottle packaging practices.
The U.S. Food and Drug Administration issued a recall Tuesday, warning the bottles potentially contain foreign tablets, caplets, or capsules which could result in the unintended mixing of medications. Consumers are being cautioned that having two products mixed together could lead to a lower or higher pill strength leading to an overdose risk, an allergic reaction to an unintended ingredient or an interaction with other drugs.
Health Canada advises people with concerns about the products affected by the recall to consult their health-care practitioner. For recall information or tips on how to return the Excedrin products, Novartis Consumer Health Canada Inc.’s consumer relationship centre can be reached at 1-888-788-8181.